Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

COVID-19

Displaying 1 to 10 of 34 Posts . Displaying 10 of Posts . Page of 4 . Go To Page: . Per Page: . . . View All Sort By: .

Commentary: NPF COVID-19 Task Force Guidance Statements

Recently, the Task Force (TF) of the National Psoriasis Foundation (NPF) released a revised version of its COVID-19 statement after an in-depth analysis of publicly available data with two currently approved anti-SARS-CoV-2 vaccines in the US, both mRNA-based.

Read More

IPC Statement on SARS-CoV-2 Vaccines and Psoriasis

While the news of a potential SARS-CoV-2 vaccine is to be welcomed, the impact of psoriasis therapy, particularly systemic therapy, on the effectiveness and safety of vaccines needs to be considered.

Read More

Commentary: Factors associated with adverse COVID-19 outcomes in patients with psoriasis – insights from a global registry-based study

Commentary provided on this international moderate-severe psoriasis case series, where biologics use was associated with lower risk of COVID-19-related hospitalization than non-biologic systemic therapies, however further investigation is warranted due to potential selection bias and unmeasured confounding.

Read More

Global registry-based study reveals biologics use is associated with lower risk of COVID-19-related hospitalizations

According to a new paper published by the team behind the PsoProtect registry, psoriasis patients treated with biologics are at a lower risk of being hospitalized due to COVID-19 than those treated with non-biologic systemic therapies.

Read More

PsoProtect registry data on first 200 cases

PsoProtect, the global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data so that it now includes the first 200 cases.

Read More

Commentary: National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease

IPC Founding President Alan Menter and IPC Councilor Ulrich Mrowietz discuss the new guidance on psoriasis care from the National Psoriasis Foundation COVID-19 Task Force.

Read More

Declaración sobre el brote de coronavirus

Declaración del IPC sobre COVID y psoriasis La pandemia de SARS-CoV-2 continúa siendo una preocupación sanitaria de gravedad a nivel global. Desde que el Consejo Internacional de Psoriasis (IPC) publicó su declaración sobre COVID-19 el 11 de marzo, el coronavirus continúa propagándose rápidamente y actualmente constituye un peligro sanitario preponderante en todos los países de ingresos económicos altos, medios y bajos.

Read More

Spanish study identifies 5 skin manifestations in COVID-19 patients

IPC fellow Dr. Romina Contreras talks with Dr. Alba Català about her study on skin manifestations of COVID-19 and how this research contributes to our growing understanding of the novel coronavirus.

Read More

Stories from the field: COVID-19 and dermatology practice in Brazil

Ricardo Romiti, MD, PhD, discusses the COVID-19 situation in Brazil from a derm perspective.

Read More

How to build a registry in record time: an interview with Catherine Smith and Satveer Mahil

The registries, PsoProtect and PsoProtectMe, aim to help health care workers understand how the novel virus affects patients with psoriasis.

Read More

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.
SUBSCRIBE

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now

Search Our Blog

  Search
 

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK